{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000009", "version": 4, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2001-06-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Tournamille et al. (1998) and Olsson et al. (1998) described a Duffy allele, FYB-weak (FYB-WK), or FYX, in approximately 3.5% of the population that, because of an arg89-to-cys (R89C) substitution in the first cytoplasmic domain of DARC, results in reduced levels of protein, lower antigen expression, and reduced ability to bind chemokines. The phenotype is called Fy(bwk), Fy(x), or either Fy(a-b+(weak)) or Fy(a+b+(weak)). The R89C substitution results from a C-to-T change at nucleotide 286 of the DARC gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "9731074"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "9886340"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Parasol et al. (1998) noted that, in addition to West African blacks, the Duffy-null phenotype also occurs in non-Ashkenazi Jews, being found, for example, in approximately 20% of Jews from Yemen. They found that in some of these cases Fy(b-) individuals had the wildtype FY*B GATA but carried 271C-T and 304G-A mutations. The 271C-T substitution resulted in an R91C amino acid substitution (R89C in the predominant DARC isoform reported by Iwamoto et al. (1996)), which represented a considerable change of chemical nature, one that may affect the antigenic determinants of DARC, and thus may be of clinical significance. Parasol et al. (1998) noted that further studies were needed to determine whether erythrocytes carrying these mutations behave as Fy(bwk) variants."}, "citations": [{"ids": [{"source": "PubMed", "value": "8547665"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "9746760"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Carrington et al. (1997) described a CCR5 (601373) allele that carries a single amino acid substitution (R60S; 601373.0008) in the first intracellular domain of the protein that in heterozygous state appears to protect against human immunodeficiency virus (HIV) infection (see 609423). Tamasauskas et al. (2001) showed that in both the CCR5 R60S and DARC R89C alleles, the loss of a positive charge from the intracellular loop leads to reduced surface expression, thereby identifying a novel mechanism that may be protective against disease: against malarial infection by Plasmodium vivax in the case of the DARC gene and against AIDS in the case of the CCR5 gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "11369664"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "9399903"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000018396", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_002036.4(ACKR1):c.265C>T (p.Arg89Cys)"}}], "canonical_spdi": "NC_000001.11:159205703:C:T", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_801t1:c.265C>T"}, {"type": "HGVS, coding, RefSeq", "value": "NM_002036.4:c.265C>T"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001122951.3:c.271C>T"}, {"type": "HGVS, genomic, LRG", "value": "LRG_801:g.6692C>T"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_011626.3:g.6692C>T"}, {"type": "HGVS, genomic, top level", "value": "NC_000001.11:g.159205704C>T"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000001.10:g.159175494C>T"}, {"type": "HGVS, protein"}, {"type": "HGVS, protein", "value": "LRG_801p1:p.Arg89Cys"}, {"type": "HGVS, protein", "value": "Q16570:p.Arg89Cys"}, {"type": "HGVS, protein, RefSeq", "value": "NP_002027.2:p.Arg89Cys"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001116423.1:p.Arg91Cys"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_001122951.3:c.271C>T"}]}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_002036.4:c.265C>T"}]}, {"type": "ProteinChange1LetterCode", "value": "R89C"}, {"type": "ProteinChange1LetterCode", "value": "R91C"}, {"type": "ProteinChange3LetterCode", "value": "ARG89CYS"}], "global_minor_allele_frequency": {"value": 0.00459, "source": "1000 Genomes Project", "minor_allele": "T"}, "sequence_location": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 159205704, "stop": 159205704, "display_start": 159205704, "display_stop": 159205704, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 159205704, "reference_allele_vcf": "C", "alternate_allele_vcf": "T"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 159175494, "stop": 159175494, "display_start": 159175494, "display_stop": 159175494, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 159175494, "reference_allele_vcf": "C", "alternate_allele_vcf": "T"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "atypical chemokine receptor 1 (Duffy blood group)"}}], "symbols": [{"value": {"type": "Preferred", "value": "ACKR1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 159204875, "stop": 159206500, "display_start": 159204875, "display_stop": 159206500, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 159173802, "stop": 159176289, "display_start": 159173802, "display_stop": 159176289, "strand": "+", "variant_length": 2488, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "2532"}, {"db": "OMIM", "id": "613665", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:4035"}]}], "xrefs": [{"db": "UniProtKB", "id": "Q16570#VAR_015068"}, {"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}, {"db": "dbSNP", "id": "34599082", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_002036.4(ACKR1):c.265C>T (p.Arg89Cys)"}}], "xrefs": [{"db": "ClinGen", "id": "CA113789"}], "id": 18396}, "traits": {"type": "Disease", "traits": [{"type": "BloodGroup", "names": [{"value": {"type": "Preferred", "value": "DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE"}, "xrefs": [{"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}]}]}], "id": 6213}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57512}, "record_status": "current", "title": "NM_002036.4(ACKR1):c.265C>T (p.Arg89Cys) AND DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE", "clinvar_assertions": [{"id": 20152, "submission_id": {"local_key": "613665.0003_DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE", "submitter": "OMIM", "title": "ACKR1, ARG89CYS_DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE", "submitter_date": "2017-12-11"}, "clinvar_accession": {"acc": "SCV000020152", "version": 3, "type": "SCV", "date_updated": "2017-12-15", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2001-06-01"}], "external_ids": [{"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Tournamille et al. (1998) and Olsson et al. (1998) described a Duffy allele, FYB-weak (FYB-WK), or FYX, in approximately 3.5% of the population that, because of an arg89-to-cys (R89C) substitution in the first cytoplasmic domain of DARC, results in reduced levels of protein, lower antigen expression, and reduced ability to bind chemokines. The phenotype is called Fy(bwk), Fy(x), or either Fy(a-b+(weak)) or Fy(a+b+(weak)). The R89C substitution results from a C-to-T change at nucleotide 286 of the DARC gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "9731074"}]}, {"ids": [{"source": "PubMed", "value": "9886340"}]}]}, {"attribute": {"type": "Description", "value": "Parasol et al. (1998) noted that, in addition to West African blacks, the Duffy-null phenotype also occurs in non-Ashkenazi Jews, being found, for example, in approximately 20% of Jews from Yemen. They found that in some of these cases Fy(b-) individuals had the wildtype FY*B GATA but carried 271C-T and 304G-A mutations. The 271C-T substitution resulted in an R91C amino acid substitution (R89C in the predominant DARC isoform reported by Iwamoto et al. (1996)), which represented a considerable change of chemical nature, one that may affect the antigenic determinants of DARC, and thus may be of clinical significance. Parasol et al. (1998) noted that further studies were needed to determine whether erythrocytes carrying these mutations behave as Fy(bwk) variants."}, "citations": [{"ids": [{"source": "PubMed", "value": "9746760"}]}, {"ids": [{"source": "PubMed", "value": "8547665"}]}]}, {"attribute": {"type": "Description", "value": "Carrington et al. (1997) described a CCR5 (601373) allele that carries a single amino acid substitution (R60S; 601373.0008) in the first intracellular domain of the protein that in heterozygous state appears to protect against human immunodeficiency virus (HIV) infection (see 609423). Tamasauskas et al. (2001) showed that in both the CCR5 R60S and DARC R89C alleles, the loss of a positive charge from the intracellular loop leads to reduced surface expression, thereby identifying a novel mechanism that may be protective against disease: against malarial infection by Plasmodium vivax in the case of the DARC gene and against AIDS in the case of the CCR5 gene."}, "citations": [{"ids": [{"source": "PubMed", "value": "9399903"}]}, {"ids": [{"source": "PubMed", "value": "11369664"}]}], "xrefs": [{"db": "OMIM", "id": "601373", "type": "MIM"}, {"db": "OMIM", "id": "609423", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "ACKR1, ARG89CYS"}}], "attributes": [{"type": "NonHGVS", "value": "ARG89CYS"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "ACKR1"}}]}], "xrefs": [{"db": "OMIM", "id": "613665.0003", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "DUFFY BLOOD GROUP SYSTEM, FY(bwk) PHENOTYPE"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000010", "version": 3, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2000-04-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Mallinson et al. (1995) presented evidence for 2 different genetic backgrounds giving rise to the Fy(a-b-) phenotype. The most likely genetic mechanism in most individuals is downregulation of Duffy glycoprotein mRNA (see 613665.0002). However, the Duffy gene from a very rare Caucasian individual (AZ) with the Fy(a-b-) phenotype had a 14-bp deletion that resulted in a frameshift. In the Abstract and Results sections of their paper, Mallinson et al. (1995) reported that the deletion removed nucleotides 287 to 301 of DARC. However, their Figure 4 showed that the deletion involved nucleotides 292 to 305, which appeared to be correct. The DARC cDNA sequence used by Mallinson et al. (1995) was identical to that of the minor DARC variant reported by Chaudhuri et al. (1993). The frameshift resulting from the deletion introduced a stop codon 23 amino acids downstream and produced a putative truncated 118-amino acid protein. The occurrence of this mutation in an apparently healthy individual raised questions about the functional importance of the Duffy glycoprotein, not only in normal erythrocytes, but also in all human cells and tissues. The only known examples of the Fy(a-b-) phenotype in Caucasians were AZ and Czech gypsies."}, "citations": [{"ids": [{"source": "PubMed", "value": "7669660"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "8248172"}], "type": "general"}]}, {"attribute": {"type": "Description", "value": "Using the sequence of the major DARC variant reported by Iwamoto et al. (1996), as was recommended by Pogo and Chaudhuri (2000), this 14-bp deletion occurs at nucleotide 286."}, "citations": [{"ids": [{"source": "PubMed", "value": "8547665"}], "type": "general"}, {"ids": [{"source": "PubMed", "value": "10791881"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000018397", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_002036.4(ACKR1):c.286_299del (p.Trp96fs)"}}, {"value": {"type": "Alternate", "value": "ACKR1, 14-BP DEL, NT286"}, "xrefs": [{"db": "OMIM", "id": "613665.0004", "type": "Allelic variant"}]}], "canonical_spdi": "NC_000001.11:159205718:CCTGGCTGGCCTGTCCTGGC:CCTGGC", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_801t1:c.286_299del"}, {"type": "HGVS, coding, RefSeq", "value": "NM_002036.4:c.286_299del"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001122951.3:c.292_305del"}, {"type": "HGVS, genomic, LRG", "value": "LRG_801:g.6713_6726del"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_011626.3:g.6713_6726del"}, {"type": "HGVS, genomic, top level", "value": "NC_000001.11:g.159205725_159205738del"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000001.10:g.159175515_159175528del"}, {"type": "HGVS, previous", "value": "NM_002036.3:c.286_299del"}, {"type": "HGVS, protein"}, {"type": "HGVS, protein", "value": "LRG_801p1:p.Trp96fs"}, {"type": "HGVS, protein, RefSeq", "value": "NP_002027.2:p.Trp96fs"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001116423.1:p.Trp98fs"}, {"type": "MolecularConsequence", "value": "frameshift variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001589"}, {"db": "RefSeq", "id": "NM_001122951.3:c.292_305del"}]}, {"type": "MolecularConsequence", "value": "frameshift variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001589"}, {"db": "RefSeq", "id": "NM_002036.4:c.286_299del"}]}, {"type": "ProteinChange1LetterCode", "value": "W96fs"}, {"type": "ProteinChange1LetterCode", "value": "W98fs"}], "sequence_location": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 159205719, "stop": 159205732, "display_start": 159205719, "display_stop": 159205732, "variant_length": 14, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 159205718, "reference_allele_vcf": "CCCTGGCTGGCCTGT", "alternate_allele_vcf": "C"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 159175509, "stop": 159175522, "display_start": 159175509, "display_stop": 159175522, "variant_length": 14, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 159175508, "reference_allele_vcf": "CCCTGGCTGGCCTGT", "alternate_allele_vcf": "C"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "atypical chemokine receptor 1 (Duffy blood group)"}}], "symbols": [{"value": {"type": "Preferred", "value": "ACKR1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "1", "accession": "NC_000001.11", "start": 159204875, "stop": 159206500, "display_start": 159204875, "display_stop": 159206500, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "1", "accession": "NC_000001.10", "start": 159173802, "stop": 159176289, "display_start": 159173802, "display_stop": 159176289, "strand": "+", "variant_length": 2488, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "2532"}, {"db": "OMIM", "id": "613665", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:4035"}]}], "xrefs": [{"db": "OMIM", "id": "613665.0004", "type": "Allelic variant"}, {"db": "dbSNP", "id": "587776507", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_002036.4(ACKR1):c.286_299del (p.Trp96fs)"}}], "xrefs": [{"db": "ClinGen", "id": "CA113791"}], "id": 18397}, "traits": {"type": "Disease", "traits": [{"type": "BloodGroup", "names": [{"value": {"type": "Preferred", "value": "DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE"}, "xrefs": [{"db": "OMIM", "id": "613665.0002", "type": "Allelic variant"}, {"db": "OMIM", "id": "613665.0004", "type": "Allelic variant"}]}, {"value": {"type": "Alternate", "value": "DUFFY NULL; Fy(a-b-)"}}]}], "id": 6212}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57513}, "record_status": "current", "title": "NM_002036.4(ACKR1):c.286_299del (p.Trp96fs) AND DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE", "clinvar_assertions": [{"id": 20153, "submission_id": {"local_key": "613665.0004_DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE", "submitter": "OMIM", "title": "ACKR1, 14-BP DEL, NT286_DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE", "submitter_date": "2015-08-10"}, "clinvar_accession": {"acc": "SCV000020153", "version": 2, "type": "SCV", "date_updated": "2015-08-12", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2000-04-01"}], "external_ids": [{"db": "OMIM", "id": "613665.0004", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "Mallinson et al. (1995) presented evidence for 2 different genetic backgrounds giving rise to the Fy(a-b-) phenotype. The most likely genetic mechanism in most individuals is downregulation of Duffy glycoprotein mRNA (see 613665.0002). However, the Duffy gene from a very rare Caucasian individual (AZ) with the Fy(a-b-) phenotype had a 14-bp deletion that resulted in a frameshift. In the Abstract and Results sections of their paper, Mallinson et al. (1995) reported that the deletion removed nucleotides 287 to 301 of DARC. However, their Figure 4 showed that the deletion involved nucleotides 292 to 305, which appeared to be correct. The DARC cDNA sequence used by Mallinson et al. (1995) was identical to that of the minor DARC variant reported by Chaudhuri et al. (1993). The frameshift resulting from the deletion introduced a stop codon 23 amino acids downstream and produced a putative truncated 118-amino acid protein. The occurrence of this mutation in an apparently healthy individual raised questions about the functional importance of the Duffy glycoprotein, not only in normal erythrocytes, but also in all human cells and tissues. The only known examples of the Fy(a-b-) phenotype in Caucasians were AZ and Czech gypsies."}, "citations": [{"ids": [{"source": "PubMed", "value": "7669660"}]}, {"ids": [{"source": "PubMed", "value": "8248172"}]}]}, {"attribute": {"type": "Description", "value": "Using the sequence of the major DARC variant reported by Iwamoto et al. (1996), as was recommended by Pogo and Chaudhuri (2000), this 14-bp deletion occurs at nucleotide 286."}, "citations": [{"ids": [{"source": "PubMed", "value": "8547665"}]}, {"ids": [{"source": "PubMed", "value": "10791881"}]}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "ACKR1, 14-BP DEL, NT286"}}], "attributes": [{"type": "NonHGVS", "value": "14-BP DEL, NT286"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "ACKR1"}}]}], "xrefs": [{"db": "OMIM", "id": "613665.0004", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000012", "version": 5, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "criteria provided, single submitter", "description": "pathogenic"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 French sibs with autosomal recessive spastic paraplegia-48 (SPG48; 613647), Slabicki et al. (2010) identified a homozygous complex insertion/deletion mutation in exon 2 of the KIAA0415 gene. The mutation comprised a 4-bp deletion (80del4) and a 22-bp insertion (84ins22), resulting in a frameshift and premature stop codon following residue 29. The insertion was found to be an imperfect quadruplication of a sequence, suggesting DNA polymerase slippage during DNA synthesis as the pathogenetic mechanism. The patients presented with progressive spastic paraplegia associated with urinary incontinence from ages 50 and 49 years, respectively. One had a normal cerebral MRI, whereas the other had spinal hyperintensities in the cervical spine. The unaffected parents were not known to be consanguineous, but they originated from 2 neighboring villages. The mutation was not found in 156 Caucasian or 242 North African control chromosomes. Studies of lymphoblastoid cells derived from 1 patient showed increased sensitivity to DNA-damaging drugs. The findings suggested a link between this form of spastic paraplegia, which could be considered a neurodegenerative disease, and defects in DNA repair."}, "citations": [{"ids": [{"source": "PubMed", "value": "20613862"}], "type": "general"}]}]}, {"sample": {"origin": "unknown", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "yes"}, "methods": ["clinical testing"], "observed_data": [{"attribute": {"type": "VariantAlleles", "integer_value": 2}}]}], "measures": {"type": "Variant", "acc": "VCV000000002", "version": 3, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_014855.3(AP5Z1):c.80_83delinsTGCTGTAAACTGTAACTGTAAA (p.Arg27_Ile28delinsLeuLeuTer)"}}, {"value": {"type": "Alternate", "value": "AP5Z1, 4-BP DEL/22-BP INS, NT80"}, "xrefs": [{"db": "OMIM", "id": "613653.0001", "type": "Allelic variant"}]}], "canonical_spdi": "NC_000007.14:4781212:GGAT:TGCTGTAAACTGTAACTGTAAA", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_1247t1:c.80_83delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001364858.1:c.-202_-199delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, coding, RefSeq", "value": "NM_014855.3:c.80_83delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, genomic, LRG", "value": "LRG_1247:g.10583_10586delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_028111.1:g.10583_10586delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, genomic, top level", "value": "NC_000007.14:g.4781213_4781216delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000007.13:g.4820844_4820847delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, non-coding", "value": "NR_157345.1:n.173_176delinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, previous", "value": "NM_014855.2:c.80_83delGGATinsTGCTGTAAACTGTAACTGTAAA"}, {"type": "HGVS, protein", "value": "LRG_1247p1:p.Arg27_Ile28delinsLeuLeuTer"}, {"type": "HGVS, protein, RefSeq", "value": "NP_055670.1:p.Arg27_Ile28delinsLeuLeuTer"}, {"type": "MolecularConsequence", "value": "5 prime UTR variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001623"}, {"db": "RefSeq", "id": "NM_001364858.1:c.-202_-199delinsTGCTGTAAACTGTAACTGTAAA"}]}, {"type": "MolecularConsequence", "value": "non-coding transcript variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001619"}, {"db": "RefSeq", "id": "NR_157345.1:n.173_176delinsTGCTGTAAACTGTAACTGTAAA"}]}, {"type": "MolecularConsequence", "value": "nonsense", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001587"}, {"db": "RefSeq", "id": "NM_014855.3:c.80_83delinsTGCTGTAAACTGTAACTGTAAA"}]}], "sequence_location": [{"assembly": "GRCh38", "chr": "7", "accession": "NC_000007.14", "start": 4781213, "stop": 4781216, "display_start": 4781213, "display_stop": 4781216, "variant_length": 22, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 4781213, "reference_allele_vcf": "GGAT", "alternate_allele_vcf": "TGCTGTAAACTGTAACTGTAAA"}, {"assembly": "GRCh37", "chr": "7", "accession": "NC_000007.13", "start": 4820844, "stop": 4820847, "display_start": 4820844, "display_stop": 4820847, "variant_length": 22, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 4820844, "reference_allele_vcf": "GGAT", "alternate_allele_vcf": "TGCTGTAAACTGTAACTGTAAA"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "adaptor related protein complex 5 subunit zeta 1"}}], "symbols": [{"value": {"type": "Preferred", "value": "AP5Z1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "7", "accession": "NC_000007.14", "start": 4775623, "stop": 4794397, "display_start": 4775623, "display_stop": 4794397, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "7", "accession": "NC_000007.13", "start": 4815261, "stop": 4834025, "display_start": 4815261, "display_stop": 4834025, "strand": "+", "variant_length": 18765, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "9907"}, {"db": "OMIM", "id": "613653", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:22197"}]}], "citations": [{"ids": [{"source": "PubMed", "value": "20613862"}], "type": "general"}], "xrefs": [{"db": "OMIM", "id": "613653.0001", "type": "Allelic variant"}, {"db": "dbSNP", "id": "397704705", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_014855.3(AP5Z1):c.80_83delinsTGCTGTAAACTGTAACTGTAAA (p.Arg27_Ile28delinsLeuLeuTer)"}}], "xrefs": [{"db": "ClinGen", "id": "CA215070"}], "id": 2}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Hereditary spastic paraplegia 48"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0013342"}]}, {"value": {"type": "Alternate", "value": "Spastic paraplegia 48, autosomal recessive"}, "xrefs": [{"db": "Genetic Alliance", "id": "Spastic+paraplegia+48%2C+autosomal+recessive/9323"}]}, {"value": {"type": "Alternate", "value": "Spastic paraplegia 48"}}], "symbols": [{"value": {"type": "Alternate", "value": "SPG48"}, "xrefs": [{"db": "OMIM", "id": "613647", "type": "MIM"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0013342"}, {"db": "MedGen", "id": "C3150901"}, {"db": "Orphanet", "id": "306511"}, {"db": "OMIM", "id": "613647", "type": "MIM"}]}], "id": 2}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57515}, "record_status": "current", "title": "NM_014855.3(AP5Z1):c.80_83delinsTGCTGTAAACTGTAACTGTAAA (p.Arg27_Ile28delinsLeuLeuTer) AND Hereditary spastic paraplegia 48", "clinvar_assertions": [{"id": 20155, "submission_id": {"local_key": "613653.0001_SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE", "submitter": "OMIM", "title": "AP5Z1, 4-BP DEL/22-BP INS, NT80_SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE", "submitter_date": "2017-01-26"}, "clinvar_accession": {"acc": "SCV000020155", "version": 3, "type": "SCV", "date_updated": "2017-01-30", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-06-29"}], "external_ids": [{"db": "OMIM", "id": "613653.0001", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 French sibs with autosomal recessive spastic paraplegia-48 (SPG48; 613647), Slabicki et al. (2010) identified a homozygous complex insertion/deletion mutation in exon 2 of the KIAA0415 gene. The mutation comprised a 4-bp deletion (80del4) and a 22-bp insertion (84ins22), resulting in a frameshift and premature stop codon following residue 29. The insertion was found to be an imperfect quadruplication of a sequence, suggesting DNA polymerase slippage during DNA synthesis as the pathogenetic mechanism. The patients presented with progressive spastic paraplegia associated with urinary incontinence from ages 50 and 49 years, respectively. One had a normal cerebral MRI, whereas the other had spinal hyperintensities in the cervical spine. The unaffected parents were not known to be consanguineous, but they originated from 2 neighboring villages. The mutation was not found in 156 Caucasian or 242 North African control chromosomes. Studies of lymphoblastoid cells derived from 1 patient showed increased sensitivity to DNA-damaging drugs. The findings suggested a link between this form of spastic paraplegia, which could be considered a neurodegenerative disease, and defects in DNA repair."}, "citations": [{"ids": [{"source": "PubMed", "value": "20613862"}]}], "xrefs": [{"db": "OMIM", "id": "613647", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "AP5Z1, 4-BP DEL/22-BP INS, NT80"}}], "attributes": [{"type": "NonHGVS", "value": "4-BP DEL/22-BP INS, NT80"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "AP5Z1"}}]}], "xrefs": [{"db": "OMIM", "id": "613653.0001", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE"}}]}]}}, {"id": 2865972, "submission_id": {"local_key": "NM_014855.3:c.80_83delinsTGCTGTAAACTGTAACTGTAAA|OMIM:613647", "submitter": "Paris Brain Institute, Inserm - ICM", "submitted_assembly": "GRCh37", "submitter_date": "2020-11-14"}, "clinvar_accession": {"acc": "SCV001451119", "version": 1, "type": "SCV", "date_updated": "2021-05-16", "date_created": "2021-05-16", "org_id": "507826", "org_type": "primary", "org_category": "laboratory"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "criteria provided, single submitter", "descriptions": ["pathogenic"]}], "attributes": [{"attribute": {"type": "AssertionMethod", "value": "ACMG Guidelines, 2015"}, "citations": [{"ids": [{"source": "PubMed", "value": "25741868"}]}]}], "observed_in": [{"sample": {"origin": "unknown", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "yes"}, "methods": ["clinical testing"], "observed_data": [{"attribute": {"type": "VariantAlleles", "integer_value": 2}}]}], "measures": {"type": "Variant", "measures": [{"attributes": [{"type": "HGVS", "value": "NM_014855.3:c.80_83delinsTGCTGTAAACTGTAACTGTAAA"}]}]}, "traits": {"type": "Disease", "traits": [{"xrefs": [{"db": "OMIM", "id": "613647", "type": "MIM"}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000013", "version": 6, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2010-06-29"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a patient with sporadic SPG48 (613647), Slabicki et al. (2010) identified a heterozygous 14-bp deletion (1413del14) in the KIAA0415 gene, resulting in a frameshift and premature termination following residue 56. No family members were available for study, and no copy number variations were found on chromosome 7, but a second small change affecting the KIAA0415 gene could not be completely excluded. The mutation was not found in 158 Caucasian or 84 North African control chromosomes."}, "citations": [{"ids": [{"source": "PubMed", "value": "20613862"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000000003", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_014855.3(AP5Z1):c.1413_1426del (p.Leu473fs)"}}, {"value": {"type": "Alternate", "value": "AP5Z1, 14-BP DEL, NT1413"}, "xrefs": [{"db": "OMIM", "id": "613653.0002", "type": "Allelic variant"}]}], "canonical_spdi": "NC_000007.14:4787729:CTGCTGGACCTGCCCTGCT:CTGCT", "attributes": [{"type": "HGVS, coding, LRG", "value": "LRG_1247t1:c.1413_1426del"}, {"type": "HGVS, coding, RefSeq", "value": "NM_014855.3:c.1413_1426del"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001364858.1:c.945_958del"}, {"type": "HGVS, genomic, LRG", "value": "LRG_1247:g.17105_17118del"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_028111.1:g.17105_17118del"}, {"type": "HGVS, genomic, top level", "value": "NC_000007.14:g.4787735_4787748del"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000007.13:g.4827366_4827379del"}, {"type": "HGVS, non-coding", "value": "NR_157345.1:n.1544_1557del"}, {"type": "HGVS, previous", "value": "NM_014855.2:c.1413_1426del"}, {"type": "HGVS, protein", "value": "LRG_1247p1:p.Leu473fs"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001351787.1:p.Leu317fs"}, {"type": "HGVS, protein, RefSeq", "value": "NP_055670.1:p.Leu473fs"}, {"type": "MolecularConsequence", "value": "frameshift variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001589"}, {"db": "RefSeq", "id": "NM_001364858.1:c.945_958del"}]}, {"type": "MolecularConsequence", "value": "frameshift variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001589"}, {"db": "RefSeq", "id": "NM_014855.3:c.1413_1426del"}]}, {"type": "MolecularConsequence", "value": "non-coding transcript variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001619"}, {"db": "RefSeq", "id": "NR_157345.1:n.1544_1557del"}]}, {"type": "ProteinChange1LetterCode", "value": "L317fs"}, {"type": "ProteinChange1LetterCode", "value": "L473fs"}], "sequence_location": [{"assembly": "GRCh38", "chr": "7", "accession": "NC_000007.14", "start": 4787730, "stop": 4787743, "display_start": 4787730, "display_stop": 4787743, "variant_length": 14, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 4787729, "reference_allele_vcf": "GCTGCTGGACCTGCC", "alternate_allele_vcf": "G"}, {"assembly": "GRCh37", "chr": "7", "accession": "NC_000007.13", "start": 4827361, "stop": 4827374, "display_start": 4827361, "display_stop": 4827374, "variant_length": 14, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 4827360, "reference_allele_vcf": "GCTGCTGGACCTGCC", "alternate_allele_vcf": "G"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "adaptor related protein complex 5 subunit zeta 1"}}], "symbols": [{"value": {"type": "Preferred", "value": "AP5Z1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "7", "accession": "NC_000007.14", "start": 4775623, "stop": 4794397, "display_start": 4775623, "display_stop": 4794397, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "7", "accession": "NC_000007.13", "start": 4815261, "stop": 4834025, "display_start": 4815261, "display_stop": 4834025, "strand": "+", "variant_length": 18765, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "9907"}, {"db": "OMIM", "id": "613653", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:22197"}]}], "xrefs": [{"db": "OMIM", "id": "613653.0002", "type": "Allelic variant"}, {"db": "dbSNP", "id": "397704709", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_014855.3(AP5Z1):c.1413_1426del (p.Leu473fs)"}}], "xrefs": [{"db": "ClinGen", "id": "CA215072"}], "id": 3}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Hereditary spastic paraplegia 48"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0013342"}]}, {"value": {"type": "Alternate", "value": "Spastic paraplegia 48, autosomal recessive"}, "xrefs": [{"db": "Genetic Alliance", "id": "Spastic+paraplegia+48%2C+autosomal+recessive/9323"}]}, {"value": {"type": "Alternate", "value": "Spastic paraplegia 48"}}], "symbols": [{"value": {"type": "Alternate", "value": "SPG48"}, "xrefs": [{"db": "OMIM", "id": "613647", "type": "MIM"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0013342"}, {"db": "MedGen", "id": "C3150901"}, {"db": "Orphanet", "id": "306511"}, {"db": "OMIM", "id": "613647", "type": "MIM"}]}], "id": 2}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57516}, "record_status": "current", "title": "NM_014855.3(AP5Z1):c.1413_1426del (p.Leu473fs) AND Hereditary spastic paraplegia 48", "clinvar_assertions": [{"id": 20156, "submission_id": {"local_key": "613653.0002_SPASTIC PARAPLEGIA 48", "submitter": "OMIM", "title": "AP5Z1, 14-BP DEL, NT1413_SPASTIC PARAPLEGIA 48", "submitter_date": "2017-01-26"}, "clinvar_accession": {"acc": "SCV000020156", "version": 5, "type": "SCV", "date_updated": "2017-01-30", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-06-29"}], "external_ids": [{"db": "OMIM", "id": "613653.0002", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a patient with sporadic SPG48 (613647), Slabicki et al. (2010) identified a heterozygous 14-bp deletion (1413del14) in the KIAA0415 gene, resulting in a frameshift and premature termination following residue 56. No family members were available for study, and no copy number variations were found on chromosome 7, but a second small change affecting the KIAA0415 gene could not be completely excluded. The mutation was not found in 158 Caucasian or 84 North African control chromosomes."}, "citations": [{"ids": [{"source": "PubMed", "value": "20613862"}]}], "xrefs": [{"db": "OMIM", "id": "613647", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "AP5Z1, 14-BP DEL, NT1413"}}], "attributes": [{"type": "NonHGVS", "value": "14-BP DEL, NT1413"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "AP5Z1"}}]}], "xrefs": [{"db": "OMIM", "id": "613653.0002", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "SPASTIC PARAPLEGIA 48"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000016", "version": 6, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2010-10-01"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "For discussion of the asn430-to-ser (N430S) mutation in the FOXRED1 gene that was found in compound heterozygous state in a patient with mitochondrial complex I deficiency nuclear type 19 (MC1DN19; 618241) manifesting as Leigh syndrome (see 252010), by Calvo et al. (2010), see 613622.0001."}, "citations": [{"ids": [{"source": "PubMed", "value": "20818383"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000000006", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_017547.4(FOXRED1):c.1289A>G (p.Asn430Ser)"}}], "canonical_spdi": "NC_000011.10:126277516:A:G", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_017547.4:c.1289A>G"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_028029.1:g.13478A>G"}, {"type": "HGVS, genomic, top level", "value": "NC_000011.10:g.126277517A>G"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000011.9:g.126147412A>G"}, {"type": "HGVS, non-coding", "value": "NR_037647.2:n.1121A>G"}, {"type": "HGVS, non-coding", "value": "NR_037648.2:n.1466A>G"}, {"type": "HGVS, protein", "value": "Q96CU9:p.Asn430Ser"}, {"type": "HGVS, protein, RefSeq", "value": "NP_060017.1:p.Asn430Ser"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_017547.4:c.1289A>G"}]}, {"type": "MolecularConsequence", "value": "non-coding transcript variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001619"}, {"db": "RefSeq", "id": "NR_037647.2:n.1121A>G"}]}, {"type": "MolecularConsequence", "value": "non-coding transcript variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001619"}, {"db": "RefSeq", "id": "NR_037648.2:n.1466A>G"}]}, {"type": "ProteinChange1LetterCode", "value": "N430S"}, {"type": "ProteinChange3LetterCode", "value": "ASN430SER"}], "sequence_location": [{"assembly": "GRCh38", "chr": "11", "accession": "NC_000011.10", "start": 126277517, "stop": 126277517, "display_start": 126277517, "display_stop": 126277517, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 126277517, "reference_allele_vcf": "A", "alternate_allele_vcf": "G"}, {"assembly": "GRCh37", "chr": "11", "accession": "NC_000011.9", "start": 126147412, "stop": 126147412, "display_start": 126147412, "display_stop": 126147412, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 126147412, "reference_allele_vcf": "A", "alternate_allele_vcf": "G"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "FAD dependent oxidoreductase domain containing 1"}}], "symbols": [{"value": {"type": "Preferred", "value": "FOXRED1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "11", "accession": "NC_000011.10", "start": 126269154, "stop": 126278126, "display_start": 126269154, "display_stop": 126278126, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "11", "accession": "NC_000011.9", "start": 126138934, "stop": 126148026, "display_start": 126138934, "display_stop": 126148026, "strand": "+", "variant_length": 9093, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "55572"}, {"db": "OMIM", "id": "613622", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:26927"}]}], "xrefs": [{"db": "UniProtKB", "id": "Q96CU9#VAR_064571"}, {"db": "OMIM", "id": "613622.0002", "type": "Allelic variant"}, {"db": "dbSNP", "id": "267606830", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_017547.4(FOXRED1):c.1289A>G (p.Asn430Ser)"}}], "xrefs": [{"db": "ClinGen", "id": "CA113794"}], "id": 6}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Mitochondrial complex 1 deficiency, nuclear type 19"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0032624"}]}, {"value": {"type": "Alternate", "value": "MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19"}, "xrefs": [{"db": "OMIM", "id": "618241", "type": "MIM"}, {"db": "OMIM", "id": "613622.0001", "type": "Allelic variant"}, {"db": "OMIM", "id": "613622.0002", "type": "Allelic variant"}, {"db": "OMIM", "id": "613622.0003", "type": "Allelic variant"}]}], "symbols": [{"value": {"type": "Alternate", "value": "MC1DN19"}, "xrefs": [{"db": "OMIM", "id": "618241", "type": "MIM"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0032624"}, {"db": "MedGen", "id": "C4748791"}, {"db": "OMIM", "id": "618241", "type": "MIM"}]}], "id": 45335}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57519}, "record_status": "current", "title": "NM_017547.4(FOXRED1):c.1289A>G (p.Asn430Ser) AND Mitochondrial complex 1 deficiency, nuclear type 19", "clinvar_assertions": [{"id": 20159, "submission_id": {"local_key": "613622.0002_MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19", "submitter": "OMIM", "title": "FOXRED1, ASN430SER_MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19", "submitter_date": "2019-01-31"}, "clinvar_accession": {"acc": "SCV000020159", "version": 5, "type": "SCV", "date_updated": "2019-02-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-10-01"}], "external_ids": [{"db": "OMIM", "id": "613622.0002", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "For discussion of the asn430-to-ser (N430S) mutation in the FOXRED1 gene that was found in compound heterozygous state in a patient with mitochondrial complex I deficiency nuclear type 19 (MC1DN19; 618241) manifesting as Leigh syndrome (see 252010), by Calvo et al. (2010), see 613622.0001."}, "citations": [{"ids": [{"source": "PubMed", "value": "20818383"}]}], "xrefs": [{"db": "OMIM", "id": "618241", "type": "MIM"}, {"db": "OMIM", "id": "252010", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "FOXRED1, ASN430SER"}}], "attributes": [{"type": "NonHGVS", "value": "ASN430SER"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "FOXRED1"}}]}], "xrefs": [{"db": "OMIM", "id": "613622.0002", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000042", "version": 4, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2010-09-10"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 3 affected members of a family from the United Arab Emirates with polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC; 612674), Fiskerstrand et al. (2010) identified a homozygous 14-kb deletion and 2-bp insertion (del14007insGG) in the ABHD12 gene encompassing the promoter region and exon 1 of the gene. Two patients were in their twenties, and 1 was age 6 years. Common features included absent tendon reflexes, hearing loss, ataxia, cataracts; hearing loss occurred in childhood in all 3. Only the older 2 patients had retinitis pigmentosa."}, "citations": [{"ids": [{"source": "PubMed", "value": "20797687"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000000025", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_015600.4(ABHD12):c.-6898_191+7002delinsCC"}}], "attributes": [{"type": "HGVS, genomic, top level", "value": "NC_000020.11:g.25383511_25397600delinsG"}, {"type": "HGVS, genomic, top level", "value": "NC_000020.11:g.25383511_25397601delinsGG"}, {"type": "HGVS, genomic, top level, other", "value": "NC_000020.10:g.25364147_25378237del14091insGG"}, {"type": "HGVS, genomic, top level, other", "value": "NC_000020.11:g.25383511_25397601del14091insGG"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000020.10:g.25364147_25378237delinsGG"}, {"type": "HGVS, previous", "value": "NM_015600.4:c.-6898_191+7002delinsCC"}, {"type": "nucleotide change", "value": "14-KB DEL"}], "sequence_location": [{"assembly": "GRCh38", "chr": "20", "accession": "NC_000020.11", "start": 25383511, "stop": 25397601, "display_start": 25383511, "display_stop": 25397601, "variant_length": 14091, "alternate_allele": "GG", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "20", "accession": "NC_000020.10", "start": 25364147, "stop": 25378237, "display_start": 25364147, "display_stop": 25378237, "variant_length": 14091, "alternate_allele": "GG", "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "abhydrolase domain containing 12, lysophospholipase"}}], "symbols": [{"value": {"type": "Preferred", "value": "ABHD12"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "20", "accession": "NC_000020.11", "start": 25294743, "stop": 25390835, "display_start": 25294743, "display_stop": 25390835, "strand": "-", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "20", "accession": "NC_000020.10", "start": 25275378, "stop": 25371617, "display_start": 25275378, "display_stop": 25371617, "strand": "-", "variant_length": 96240, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "26090"}, {"db": "OMIM", "id": "613599", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:15868"}]}], "xrefs": [{"db": "dbVar", "id": "nssv3761628"}, {"db": "dbVar", "id": "nsv1067853"}, {"db": "OMIM", "id": "613599.0002", "type": "Allelic variant"}], "comments": [{"text": "The location of this deletion was determined from analysis of Fig. S4C in PubMed 20797687.", "type": "public", "datasource": "NCBI curation"}, {"text": "Deletion of exon 1 plus flanking sequences from ABHD12 (NG_028119.1), with insertion of GG", "type": "public", "datasource": "NCBI curation"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_015600.4(ABHD12):c.-6898_191+7002delinsCC"}}], "id": 25}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "PHARC syndrome"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0012984"}]}, {"value": {"type": "Alternate", "value": "Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract"}, "xrefs": [{"db": "Genetic Alliance", "id": "Polyneuropathy%2C+hearing+loss%2C+ataxia%2C+retinitis+pigmentosa%2C+and+cataract/9132"}]}, {"value": {"type": "Alternate", "value": "Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome"}, "xrefs": [{"db": "Orphanet", "id": "171848"}]}], "symbols": [{"value": {"type": "Alternate", "value": "PHARC"}, "xrefs": [{"db": "OMIM", "id": "612674", "type": "MIM"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0012984"}, {"db": "MedGen", "id": "C2675204"}, {"db": "Orphanet", "id": "171848"}, {"db": "OMIM", "id": "612674", "type": "MIM"}]}], "id": 17}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57545}, "record_status": "current", "title": "NM_015600.4(ABHD12):c.-6898_191+7002delinsCC AND PHARC syndrome", "clinvar_assertions": [{"id": 20185, "submission_id": {"local_key": "613599.0002_POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT", "submitter": "OMIM", "title": "ABHD12, 14-KB DEL_POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT", "submitter_date": "2018-10-03"}, "clinvar_accession": {"acc": "SCV000020185", "version": 3, "type": "SCV", "date_updated": "2018-10-10", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-09-10"}], "external_ids": [{"db": "OMIM", "id": "613599.0002", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 3 affected members of a family from the United Arab Emirates with polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC; 612674), Fiskerstrand et al. (2010) identified a homozygous 14-kb deletion and 2-bp insertion (del14007insGG) in the ABHD12 gene encompassing the promoter region and exon 1 of the gene. Two patients were in their twenties, and 1 was age 6 years. Common features included absent tendon reflexes, hearing loss, ataxia, cataracts; hearing loss occurred in childhood in all 3. Only the older 2 patients had retinitis pigmentosa."}, "citations": [{"ids": [{"source": "PubMed", "value": "20797687"}]}], "xrefs": [{"db": "OMIM", "id": "612674", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "ABHD12, 14-KB DEL"}}], "attributes": [{"type": "NonHGVS", "value": "14-KB DEL"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "ABHD12"}}]}], "xrefs": [{"db": "OMIM", "id": "613599.0002", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000043", "version": 3, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2010-09-10"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 7 patients from 4 Algerian families with polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC; 612674), Fiskerstrand et al. (2010) identified a homozygous 7-bp duplication in exon 9 of the ABHD12 gene (846_852dupTAAGAGC), resulting in a premature stop codon at residue 285. The patients ranged in age from 10 to 44 years. The older individuals were more severely affected. All patients had some evidence of a polyneuropathy, with hyporeflexia, pes cavus, and/or sensory loss, and most had gait ataxia with onset in the childhood. Four of the older patients had hearing loss, but only 1 had retinitis pigmentosa and cataract. Other common features included extensor plantar responses and cerebellar atrophy."}, "citations": [{"ids": [{"source": "PubMed", "value": "20797687"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000000026", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_001042472.3(ABHD12):c.846_852dup (p.His285Ter)"}}], "canonical_spdi": "NC_000020.11:25307980:GCTCTTAGCT:GCTCTTAGCTCTTAGCT", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_001042472.3:c.846_852dup"}, {"type": "HGVS, coding, RefSeq", "value": "NM_015600.5:c.846_852dup"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_028119.1:g.87996_88002dup"}, {"type": "HGVS, genomic, top level", "value": "NC_000020.11:g.25307984_25307990dup"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000020.10:g.25288620_25288626dup"}, {"type": "HGVS, previous", "value": "NM_015600.4:c.846_852dup"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001035937.1:p.His285Ter"}, {"type": "HGVS, protein, RefSeq", "value": "NP_056415.1:p.His285Ter"}, {"type": "MolecularConsequence", "value": "nonsense", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001587"}, {"db": "RefSeq", "id": "NM_001042472.3:c.846_852dup"}]}, {"type": "MolecularConsequence", "value": "nonsense", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001587"}, {"db": "RefSeq", "id": "NM_015600.5:c.846_852dup"}]}, {"type": "ProteinChange1LetterCode", "value": "H285*"}], "sequence_location": [{"assembly": "GRCh38", "chr": "20", "accession": "NC_000020.11", "start": 25307980, "stop": 25307981, "display_start": 25307980, "display_stop": 25307981, "variant_length": 7, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 25307980, "reference_allele_vcf": "G", "alternate_allele_vcf": "GGCTCTTA"}, {"assembly": "GRCh37", "chr": "20", "accession": "NC_000020.10", "start": 25288616, "stop": 25288617, "display_start": 25288616, "display_stop": 25288617, "variant_length": 7, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 25288616, "reference_allele_vcf": "G", "alternate_allele_vcf": "GGCTCTTA"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "abhydrolase domain containing 12, lysophospholipase"}}], "symbols": [{"value": {"type": "Preferred", "value": "ABHD12"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "20", "accession": "NC_000020.11", "start": 25294743, "stop": 25390835, "display_start": 25294743, "display_stop": 25390835, "strand": "-", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "20", "accession": "NC_000020.10", "start": 25275378, "stop": 25371617, "display_start": 25275378, "display_stop": 25371617, "strand": "-", "variant_length": 96240, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "26090"}, {"db": "OMIM", "id": "613599", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:15868"}]}], "xrefs": [{"db": "OMIM", "id": "613599.0003", "type": "Allelic variant"}, {"db": "dbSNP", "id": "397704714", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_001042472.3(ABHD12):c.846_852dup (p.His285Ter)"}}], "xrefs": [{"db": "ClinGen", "id": "CA113810"}], "id": 26}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "PHARC syndrome"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0012984"}]}, {"value": {"type": "Alternate", "value": "Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract"}, "xrefs": [{"db": "Genetic Alliance", "id": "Polyneuropathy%2C+hearing+loss%2C+ataxia%2C+retinitis+pigmentosa%2C+and+cataract/9132"}]}, {"value": {"type": "Alternate", "value": "Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome"}, "xrefs": [{"db": "Orphanet", "id": "171848"}]}], "symbols": [{"value": {"type": "Alternate", "value": "PHARC"}, "xrefs": [{"db": "OMIM", "id": "612674", "type": "MIM"}]}], "xrefs": [{"db": "MONDO", "id": "MONDO:0012984"}, {"db": "MedGen", "id": "C2675204"}, {"db": "Orphanet", "id": "171848"}, {"db": "OMIM", "id": "612674", "type": "MIM"}]}], "id": 17}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57546}, "record_status": "current", "title": "NM_001042472.3(ABHD12):c.846_852dup (p.His285Ter) AND PHARC syndrome", "clinvar_assertions": [{"id": 20186, "submission_id": {"local_key": "613599.0003_POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT", "submitter": "OMIM", "title": "ABHD12, 7-BP DUP, NT846_POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT", "submitter_date": "2015-05-12"}, "clinvar_accession": {"acc": "SCV000020186", "version": 2, "type": "SCV", "date_updated": "2015-05-18", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-09-10"}], "external_ids": [{"db": "OMIM", "id": "613599.0003", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 7 patients from 4 Algerian families with polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (PHARC; 612674), Fiskerstrand et al. (2010) identified a homozygous 7-bp duplication in exon 9 of the ABHD12 gene (846_852dupTAAGAGC), resulting in a premature stop codon at residue 285. The patients ranged in age from 10 to 44 years. The older individuals were more severely affected. All patients had some evidence of a polyneuropathy, with hyporeflexia, pes cavus, and/or sensory loss, and most had gait ataxia with onset in the childhood. Four of the older patients had hearing loss, but only 1 had retinitis pigmentosa and cataract. Other common features included extensor plantar responses and cerebellar atrophy."}, "citations": [{"ids": [{"source": "PubMed", "value": "20797687"}]}], "xrefs": [{"db": "OMIM", "id": "612674", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "ABHD12, 7-BP DUP, NT846"}}], "attributes": [{"type": "NonHGVS", "value": "7-BP DUP, NT846"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "ABHD12"}}]}], "xrefs": [{"db": "OMIM", "id": "613599.0003", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000049", "version": 2, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2010-09-10"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a 24-year-old woman from a European American family with calcium oxalate nephrolithiasis (HP3; 613616), Belostotsky et al. (2010) identified compound heterozygosity for an intronic G-to-T transversion (701+4G-T) in the DHDPSL gene, predicted to result in insertion of 17 amino acid residues, and glu315del (613597.0001). The unaffected parents were each heterozygous for 1 of the mutations, neither of which was found in 226 chromosomes from European American individuals."}, "citations": [{"ids": [{"source": "PubMed", "value": "20797690"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000000032", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_138413.4(HOGA1):c.700+4G>T"}}], "canonical_spdi": "NC_000010.11:97600166:G:T", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_001134670.2:c.212-1690G>T"}, {"type": "HGVS, coding, RefSeq", "value": "NM_138413.4:c.700+4G>T"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_027922.1:g.20823G>T"}, {"type": "HGVS, genomic, top level", "value": "NC_000010.11:g.97600167G>T"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000010.10:g.99359924G>T"}, {"type": "HGVS, previous", "value": "NM_138413.3:c.700+4G>T"}, {"type": "MolecularConsequence", "value": "intron variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001627"}, {"db": "RefSeq", "id": "NM_001134670.2:c.212-1690G>T"}]}, {"type": "MolecularConsequence", "value": "intron variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001627"}, {"db": "RefSeq", "id": "NM_138413.4:c.700+4G>T"}]}, {"type": "nucleotide change", "value": "IVS, G-T, +4"}], "sequence_location": [{"assembly": "GRCh38", "chr": "10", "accession": "NC_000010.11", "start": 97600167, "stop": 97600167, "display_start": 97600167, "display_stop": 97600167, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 97600167, "reference_allele_vcf": "G", "alternate_allele_vcf": "T"}, {"assembly": "GRCh37", "chr": "10", "accession": "NC_000010.10", "start": 99359924, "stop": 99359924, "display_start": 99359924, "display_stop": 99359924, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 99359924, "reference_allele_vcf": "G", "alternate_allele_vcf": "T"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "4-hydroxy-2-oxoglutarate aldolase 1"}}], "symbols": [{"value": {"type": "Preferred", "value": "HOGA1"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "10", "accession": "NC_000010.11", "start": 97584389, "stop": 97612802, "display_start": 97584389, "display_stop": 97612802, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "10", "accession": "NC_000010.10", "start": 99344101, "stop": 99372558, "display_start": 99344101, "display_stop": 99372558, "strand": "+", "variant_length": 28458, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "112817"}, {"db": "OMIM", "id": "613597", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:25155"}]}], "xrefs": [{"db": "LOVD 3", "id": "HOGA1_000005"}, {"db": "OMIM", "id": "613597.0004", "type": "Allelic variant"}, {"db": "dbSNP", "id": "2041105506", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_138413.4(HOGA1):c.700+4G>T"}}], "id": 32}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Primary hyperoxaluria type 3"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0013327"}]}, {"value": {"type": "Alternate", "value": "PH III"}}, {"value": {"type": "Alternate", "value": "Primary hyperoxaluria, type III"}, "xrefs": [{"db": "Genetic Alliance", "id": "Primary+Hyperoxaluria+Type+3/8596"}]}], "symbols": [{"value": {"type": "Alternate", "value": "HP3"}, "xrefs": [{"db": "OMIM", "id": "613616", "type": "MIM"}]}, {"value": {"type": "Alternate", "value": "HOGA1"}}, {"value": {"type": "Alternate", "value": "PH3"}}], "attributes": [{"value": {"type": "disease mechanism", "value": "loss of function"}, "xrefs": [{"db": "Genetic Testing Registry (GTR)", "id": "GTR000561373"}]}, {"value": {"type": "GARD id"}, "xrefs": [{"db": "Office of Rare Diseases", "id": "10738"}]}], "citations": [{"ids": [{"source": "PubMed", "value": "26401545"}, {"source": "BookShelf", "value": "NBK316514"}], "type": "review", "abbrev": "GeneReviews"}], "xrefs": [{"db": "MONDO", "id": "MONDO:0013327"}, {"db": "MedGen", "id": "C3150878"}, {"db": "Orphanet", "id": "416"}, {"db": "Orphanet", "id": "93600"}, {"db": "OMIM", "id": "613616", "type": "MIM"}]}], "id": 19}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57552}, "record_status": "current", "title": "NM_138413.4(HOGA1):c.700+4G>T AND Primary hyperoxaluria type 3", "clinvar_assertions": [{"id": 20192, "submission_id": {"local_key": "613597.0004_HYPEROXALURIA, PRIMARY, TYPE III", "submitter": "OMIM", "title": "HOGA1, IVS, G-T, +4_HYPEROXALURIA, PRIMARY, TYPE III", "submitter_date": "2012-11-21"}, "clinvar_accession": {"acc": "SCV000020192", "version": 1, "type": "SCV", "date_updated": "2013-04-04", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-09-10"}], "external_ids": [{"db": "OMIM", "id": "613597.0004", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In a 24-year-old woman from a European American family with calcium oxalate nephrolithiasis (HP3; 613616), Belostotsky et al. (2010) identified compound heterozygosity for an intronic G-to-T transversion (701+4G-T) in the DHDPSL gene, predicted to result in insertion of 17 amino acid residues, and glu315del (613597.0001). The unaffected parents were each heterozygous for 1 of the mutations, neither of which was found in 226 chromosomes from European American individuals."}, "citations": [{"ids": [{"source": "PubMed", "value": "20797690"}]}], "xrefs": [{"db": "OMIM", "id": "613616", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "HOGA1, IVS, G-T, +4"}}], "attributes": [{"type": "NonHGVS", "value": "IVS, G-T, +4"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "HOGA1"}}]}], "xrefs": [{"db": "OMIM", "id": "613597.0004", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "HYPEROXALURIA, PRIMARY, TYPE III"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000057", "version": 4, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2010-09-09"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 sibs with autosomal recessive microcephaly-2 and cortical malformations (MCPH2; 604317) and in an affected child from another family, all from consanguineous Turkish unions, Bilguvar et al. (2010) identified homozygosity for a 4-basepair deletion (TGCC) in exon 31 of the WDR62 gene. This deletion occurred at codon 1402 and resulted in a frameshift and premature termination (Val1402GlyfsTer12). The mutation was heterozygous in all parents. It was not observed in 1,290 Turkish control chromosomes. The index patient was a 4-year, 6-month-old female who initially presented at 4 months of age with small head size. At 2 years, 3 months she showed micrognathia and a bulbous nose, and suffered from severe mental retardation. She had had no seizures. MRI showed diffuse cortical thickening and pachygyria. The patient from the second family was a 2-year, 4 month-old male. He had microcephaly and developmental delay but no seizures. Coronal images of this patient showed findings of microlissencephaly including prominent microcephaly, bilateral Sylvian clefts, hypoplastic corpus callosum, and thickened cortex. The kinship coefficients between affected individuals from both families were consistent with fourth-degree relatedness."}, "citations": [{"ids": [{"source": "PubMed", "value": "20729831"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000000040", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_001083961.2(WDR62):c.4205_4208del (p.Val1402fs)"}}], "canonical_spdi": "NC_000019.10:36104568:TGCC:", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_173636.5:c.4190_4193del"}, {"type": "HGVS, coding, RefSeq", "value": "NM_001083961.2:c.4205_4208del"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_028101.1:g.54689_54692del"}, {"type": "HGVS, genomic, top level", "value": "NC_000019.10:g.36104569_36104572del"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000019.9:g.36595471_36595474del"}, {"type": "HGVS, previous", "value": "NM_001083961.1:c.4205_4208del"}, {"type": "HGVS, protein, RefSeq", "value": "NP_775907.4:p.Val1397fs"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001077430.1:p.Val1402fs"}, {"type": "MolecularConsequence", "value": "frameshift variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001589"}, {"db": "RefSeq", "id": "NM_001083961.2:c.4205_4208del"}]}, {"type": "MolecularConsequence", "value": "frameshift variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001589"}, {"db": "RefSeq", "id": "NM_173636.5:c.4190_4193del"}]}, {"type": "ProteinChange1LetterCode", "value": "V1397fs"}, {"type": "ProteinChange1LetterCode", "value": "V1402fs"}], "sequence_location": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 36104569, "stop": 36104572, "display_start": 36104569, "display_stop": 36104572, "variant_length": 4, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 36104568, "reference_allele_vcf": "GTGCC", "alternate_allele_vcf": "G"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 36595471, "stop": 36595474, "display_start": 36595471, "display_stop": 36595474, "variant_length": 4, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 36595470, "reference_allele_vcf": "GTGCC", "alternate_allele_vcf": "G"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "WD repeat domain 62"}}], "symbols": [{"value": {"type": "Preferred", "value": "WDR62"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 36054897, "stop": 36111145, "display_start": 36054897, "display_stop": 36111145, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 36545782, "stop": 36596011, "display_start": 36545782, "display_stop": 36596011, "strand": "+", "variant_length": 50230, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "284403"}, {"db": "OMIM", "id": "613583", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:24502"}]}], "xrefs": [{"db": "OMIM", "id": "613583.0001", "type": "Allelic variant"}, {"db": "dbSNP", "id": "397704721", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_001083961.2(WDR62):c.4205_4208del (p.Val1402fs)"}}], "xrefs": [{"db": "ClinGen", "id": "CA251360"}], "id": 40}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Microcephaly 2, primary, autosomal recessive, with or without cortical malformations"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0011435"}]}, {"value": {"type": "Alternate", "value": "Primary autosomal recessive microcephaly 2"}, "xrefs": [{"db": "Genetic Alliance", "id": "Primary+autosomal+recessive+microcephaly+2/9156"}]}, {"value": {"type": "Alternate", "value": "MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS"}, "xrefs": [{"db": "OMIM", "id": "613583.0001", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0002", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0003", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0004", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0005", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0009", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0010", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0012", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0013", "type": "Allelic variant"}]}], "symbols": [{"value": {"type": "Alternate", "value": "MCPH2"}, "xrefs": [{"db": "OMIM", "id": "604317", "type": "MIM"}]}], "attributes": [{"value": {"type": "public definition", "value": "In WDR62 primary microcephaly (WDR62-MCPH), microcephaly (occipitofrontal circumference [OFC] \u2264 -2 SD) is usually present at birth, but in some instances becomes evident later in the first year of life. Growth is otherwise normal. Except for brain malformations in most affected individuals, no other congenital malformations are observed. Central nervous system involvement can include delayed motor development, mild-to-severe intellectual disability (ID), behavior problems, epilepsy, spasticity, and ataxia."}, "xrefs": [{"db": "GeneReviews", "id": "NBK578067"}]}], "citations": [{"ids": [{"source": "PubMed", "value": "35188728"}, {"source": "BookShelf", "value": "NBK578067"}], "type": "review", "abbrev": "GeneReviews"}], "xrefs": [{"db": "MONDO", "id": "MONDO:0011435"}, {"db": "MedGen", "id": "C1858535"}, {"db": "Orphanet", "id": "2512"}, {"db": "OMIM", "id": "604317", "type": "MIM"}]}], "id": 7167}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57560}, "record_status": "current", "title": "NM_001083961.2(WDR62):c.4205_4208del (p.Val1402fs) AND Microcephaly 2, primary, autosomal recessive, with or without cortical malformations", "clinvar_assertions": [{"id": 20200, "submission_id": {"local_key": "613583.0001_MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS", "submitter": "OMIM", "title": "WDR62, 4-BP DEL, TGCC_MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS", "submitter_date": "2015-09-15"}, "clinvar_accession": {"acc": "SCV000020200", "version": 3, "type": "SCV", "date_updated": "2015-09-17", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-09-09"}], "external_ids": [{"db": "OMIM", "id": "613583.0001", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 sibs with autosomal recessive microcephaly-2 and cortical malformations (MCPH2; 604317) and in an affected child from another family, all from consanguineous Turkish unions, Bilguvar et al. (2010) identified homozygosity for a 4-basepair deletion (TGCC) in exon 31 of the WDR62 gene. This deletion occurred at codon 1402 and resulted in a frameshift and premature termination (Val1402GlyfsTer12). The mutation was heterozygous in all parents. It was not observed in 1,290 Turkish control chromosomes. The index patient was a 4-year, 6-month-old female who initially presented at 4 months of age with small head size. At 2 years, 3 months she showed micrognathia and a bulbous nose, and suffered from severe mental retardation. She had had no seizures. MRI showed diffuse cortical thickening and pachygyria. The patient from the second family was a 2-year, 4 month-old male. He had microcephaly and developmental delay but no seizures. Coronal images of this patient showed findings of microlissencephaly including prominent microcephaly, bilateral Sylvian clefts, hypoplastic corpus callosum, and thickened cortex. The kinship coefficients between affected individuals from both families were consistent with fourth-degree relatedness."}, "citations": [{"ids": [{"source": "PubMed", "value": "20729831"}]}], "xrefs": [{"db": "OMIM", "id": "604317", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "WDR62, 4-BP DEL, TGCC"}}], "attributes": [{"type": "NonHGVS", "value": "4-BP DEL, TGCC"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "WDR62"}}]}], "xrefs": [{"db": "OMIM", "id": "613583.0001", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS"}}]}]}}]}
{"reference_clinvar_assertion": {"clinvar_accession": {"acc": "RCV000000059", "version": 5, "type": "RCV", "date_updated": "2022-04-23", "date_created": "2013-04-04"}, "record_status": "current", "clinical_significance": {"review_status": "no assertion criteria provided", "description": "pathogenic", "date_last_evaluated": "2010-09-09"}, "assertion": "variation to disease", "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human", "taxonomy_id": 9606}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 sibs and their cousin with microcephaly-2 and cortical malformations (MCPH2; 604317), Bilguvar et al. (2010) identified homozygosity for a missense mutation in the WDR62 gene, a G-to-C transversion in exon 6 that converted tryptophan to serine at codon 224 (W224S). All parents were heterozygous for the mutation, which was not identified in 1,290 Turkish and 1,500 Caucasian control chromosomes. Tryptophan-224 was invariant in all species examined from human to zebrafish and lamprey. The proband was a 6-year, 5-month-old boy who presented at 2 years of age with hyperactivity, seizures, and inability to sleep. He experienced 4 to 8 seizures per day and had microcephaly, micrognathia, and severe mental retardation, and could ambulate only with assistance. The sibs were cousins of the proband. One was an 8-year, 7-month-old female who presented at age 3 with seizures. She was microcephalic, hyperactive, and had dysconjugate gaze. She was able to walk independently and had no obvious dysmorphic features but had moderate mental retardation. Her brother was 12 years, 11 months old. He had seizures, self-mutilating behavior, and severe mental retardation, but could ambulate independently."}, "citations": [{"ids": [{"source": "PubMed", "value": "20729831"}], "type": "general"}]}]}], "measures": {"type": "Variant", "acc": "VCV000000042", "version": 1, "measures": [{"names": [{"value": {"type": "Preferred", "value": "NM_001083961.2(WDR62):c.671G>C (p.Trp224Ser)"}}], "canonical_spdi": "NC_000019.10:36067414:G:C", "attributes": [{"type": "HGVS, coding, RefSeq", "value": "NM_001083961.2:c.671G>C"}, {"type": "HGVS, coding, RefSeq", "value": "NM_173636.5:c.671G>C"}, {"type": "HGVS, genomic, RefSeqGene", "value": "NG_028101.1:g.17535G>C"}, {"type": "HGVS, genomic, top level", "value": "NC_000019.10:g.36067415G>C"}, {"type": "HGVS, genomic, top level, previous", "value": "NC_000019.9:g.36558317G>C"}, {"type": "HGVS, protein", "value": "O43379:p.Trp224Ser"}, {"type": "HGVS, protein, RefSeq", "value": "NP_001077430.1:p.Trp224Ser"}, {"type": "HGVS, protein, RefSeq", "value": "NP_775907.4:p.Trp224Ser"}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_001083961.2:c.671G>C"}]}, {"type": "MolecularConsequence", "value": "missense variant", "xrefs": [{"db": "Sequence Ontology", "id": "SO:0001583"}, {"db": "RefSeq", "id": "NM_173636.5:c.671G>C"}]}, {"type": "ProteinChange1LetterCode", "value": "W224S"}, {"type": "ProteinChange3LetterCode", "value": "TRP224SER"}], "sequence_location": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 36067415, "stop": 36067415, "display_start": 36067415, "display_stop": 36067415, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current", "position_vcf": 36067415, "reference_allele_vcf": "G", "alternate_allele_vcf": "C"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 36558317, "stop": 36558317, "display_start": 36558317, "display_stop": 36558317, "variant_length": 1, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous", "position_vcf": 36558317, "reference_allele_vcf": "G", "alternate_allele_vcf": "C"}], "measure_relationship": [{"names": [{"value": {"type": "Preferred", "value": "WD repeat domain 62"}}], "symbols": [{"value": {"type": "Preferred", "value": "WDR62"}}], "sequence_locations": [{"assembly": "GRCh38", "chr": "19", "accession": "NC_000019.10", "start": 36054897, "stop": 36111145, "display_start": 36054897, "display_stop": 36111145, "strand": "+", "assembly_accesion_version": "GCF_000001405.38", "assembly_status": "current"}, {"assembly": "GRCh37", "chr": "19", "accession": "NC_000019.9", "start": 36545782, "stop": 36596011, "display_start": 36545782, "display_stop": 36596011, "strand": "+", "variant_length": 50230, "assembly_accesion_version": "GCF_000001405.25", "assembly_status": "previous"}], "xrefs": [{"db": "Gene", "id": "284403"}, {"db": "OMIM", "id": "613583", "type": "MIM"}, {"db": "HGNC", "id": "HGNC:24502"}]}], "xrefs": [{"db": "UniProtKB", "id": "O43379#VAR_063702"}, {"db": "OMIM", "id": "613583.0003", "type": "Allelic variant"}, {"db": "dbSNP", "id": "267607176", "type": "rs"}]}], "names": [{"value": {"type": "Preferred", "value": "NM_001083961.2(WDR62):c.671G>C (p.Trp224Ser)"}}], "xrefs": [{"db": "ClinGen", "id": "CA251361"}], "id": 42}, "traits": {"type": "Disease", "traits": [{"type": "Disease", "names": [{"value": {"type": "Preferred", "value": "Microcephaly 2, primary, autosomal recessive, with or without cortical malformations"}, "xrefs": [{"db": "MONDO", "id": "MONDO:0011435"}]}, {"value": {"type": "Alternate", "value": "Primary autosomal recessive microcephaly 2"}, "xrefs": [{"db": "Genetic Alliance", "id": "Primary+autosomal+recessive+microcephaly+2/9156"}]}, {"value": {"type": "Alternate", "value": "MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS"}, "xrefs": [{"db": "OMIM", "id": "613583.0001", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0002", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0003", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0004", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0005", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0009", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0010", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0012", "type": "Allelic variant"}, {"db": "OMIM", "id": "613583.0013", "type": "Allelic variant"}]}], "symbols": [{"value": {"type": "Alternate", "value": "MCPH2"}, "xrefs": [{"db": "OMIM", "id": "604317", "type": "MIM"}]}], "attributes": [{"value": {"type": "public definition", "value": "In WDR62 primary microcephaly (WDR62-MCPH), microcephaly (occipitofrontal circumference [OFC] \u2264 -2 SD) is usually present at birth, but in some instances becomes evident later in the first year of life. Growth is otherwise normal. Except for brain malformations in most affected individuals, no other congenital malformations are observed. Central nervous system involvement can include delayed motor development, mild-to-severe intellectual disability (ID), behavior problems, epilepsy, spasticity, and ataxia."}, "xrefs": [{"db": "GeneReviews", "id": "NBK578067"}]}], "citations": [{"ids": [{"source": "PubMed", "value": "35188728"}, {"source": "BookShelf", "value": "NBK578067"}], "type": "review", "abbrev": "GeneReviews"}], "xrefs": [{"db": "MONDO", "id": "MONDO:0011435"}, {"db": "MedGen", "id": "C1858535"}, {"db": "Orphanet", "id": "2512"}, {"db": "OMIM", "id": "604317", "type": "MIM"}]}], "id": 7167}, "date_created": "2013-04-04", "date_last_updated": "2022-04-23", "id": 57562}, "record_status": "current", "title": "NM_001083961.2(WDR62):c.671G>C (p.Trp224Ser) AND Microcephaly 2, primary, autosomal recessive, with or without cortical malformations", "clinvar_assertions": [{"id": 20202, "submission_id": {"local_key": "613583.0003_MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS", "submitter": "OMIM", "title": "WDR62, TRP224SER_MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS", "submitter_date": "2019-03-05"}, "clinvar_accession": {"acc": "SCV000020202", "version": 4, "type": "SCV", "date_updated": "2019-03-10", "date_created": "2013-04-04", "org_id": "3", "org_type": "primary", "org_category": "resource"}, "assertion_type": "variation to disease", "record_status": "current", "clinical_significance": [{"review_status": "no assertion criteria provided", "descriptions": ["pathogenic"], "date_last_evaluated": "2010-09-09"}], "external_ids": [{"db": "OMIM", "id": "613583.0003", "type": "Allelic variant"}], "observed_in": [{"sample": {"origin": "germline", "species": {"value": "human"}, "affected_status": "not provided"}, "methods": ["literature only"], "observed_data": [{"attribute": {"type": "Description", "value": "In 2 sibs and their cousin with microcephaly-2 and cortical malformations (MCPH2; 604317), Bilguvar et al. (2010) identified homozygosity for a missense mutation in the WDR62 gene, a G-to-C transversion in exon 6 that converted tryptophan to serine at codon 224 (W224S). All parents were heterozygous for the mutation, which was not identified in 1,290 Turkish and 1,500 Caucasian control chromosomes. Tryptophan-224 was invariant in all species examined from human to zebrafish and lamprey. The proband was a 6-year, 5-month-old boy who presented at 2 years of age with hyperactivity, seizures, and inability to sleep. He experienced 4 to 8 seizures per day and had microcephaly, micrognathia, and severe mental retardation, and could ambulate only with assistance. The sibs were cousins of the proband. One was an 8-year, 7-month-old female who presented at age 3 with seizures. She was microcephalic, hyperactive, and had dysconjugate gaze. She was able to walk independently and had no obvious dysmorphic features but had moderate mental retardation. Her brother was 12 years, 11 months old. He had seizures, self-mutilating behavior, and severe mental retardation, but could ambulate independently."}, "citations": [{"ids": [{"source": "PubMed", "value": "20729831"}]}], "xrefs": [{"db": "OMIM", "id": "604317", "type": "MIM"}]}]}], "measures": {"type": "Variant", "measures": [{"names": [{"value": {"type": "Preferred", "value": "WDR62, TRP224SER"}}], "attributes": [{"type": "NonHGVS", "value": "TRP224SER"}], "measure_relationship": [{"symbols": [{"value": {"type": "Preferred", "value": "WDR62"}}]}], "xrefs": [{"db": "OMIM", "id": "613583.0003", "type": "Allelic variant"}]}]}, "traits": {"type": "Disease", "traits": [{"names": [{"value": {"type": "Preferred", "value": "MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH CORTICAL MALFORMATIONS"}}]}]}}]}
